Clinical Practice and Cases in Emergency Medicine

Introduction: Determining a mother’s Rhesus (Rh) antigen status is a critical component of prenatal care, guiding the administration of Rh immunoglobulin (Rh Ig) to prevent Rh alloimmunization, a condition that can lead to hemolytic disease of the newborn (HDN). HDN is a blood disorder where the blood types of a mother and fetus are incompatible and causes hemolysis of the fetus’ erythrocytes, a major cause of fetal death. Rh Ig is commonly administered to Rh-negative (Rh-) women as a prophylactic measure. However, categorizing a patient’s Rh status is not always straightforward as individuals can exhibit “weakly Rh+” or “formerly Rh+” phenotypes, complicating clinical management.

Case Report: This is a case of a 28-year-old Gravida three Para two (G3P2) woman whose Rh status has varied across multiple pregnancies, who presented to the emergency department with an active miscarriage requesting a dose of Rh Ig.  Her blood typing indicated O+ status, which conflicted with her previous history of being O-.

Conclusion: Most women in the United States are Rh-positive (Rh+), which eliminates the need for Rh Ig during pregnancy. Nevertheless, there are approximately 550,000 women annually who are categorized as Rh-, and 16,700 of these cases may represent weak Rh positivity. Identifying weakly Rh+ individuals holds potential to reallocate scarce Rh Ig resources to those who require them. This report explores the clinical implications of weak Rh positivity, emphasizing maternal-fetal health considerations and the nuanced approach required to manage such cases effectively in the emergency department.